MiR-106b-5p: A Master Regulator of Potential Biomarkers for Breast Cancer Aggressiveness and Prognosis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MiR-106b-5p: A Master Regulator of Potential Biomarkers for Breast Cancer Aggressiveness and Prognosis
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 20, Pages 11135
Publisher
MDPI AG
Online
2021-10-16
DOI
10.3390/ijms222011135
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TNMplot.com: A Web Tool for the Comparison of Gene Expression in Normal, Tumor and Metastatic Tissues
- (2021) Áron Bartha et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A comprehensive review on oncogenic miRNAs in breast cancer
- (2021) Maryam Nurzadeh et al. JOURNAL OF GENETICS
- miR-106b-5p contributes to the lung metastasis of breast cancer via targeting CNN1 and regulating Rho/ROCK1 pathway
- (2020) Zheng Wang et al. Aging-US
- Visualizing and interpreting cancer genomics data via the Xena platform
- (2020) Mary J. Goldman et al. NATURE BIOTECHNOLOGY
- Hypomethylation Causes MIR21 Overexpression in Tumors
- (2020) Jun Lu et al. Molecular Therapy-Oncolytics
- MicroRNA-Dependent Targeting of RSU1 and the IPP Adhesion Complex Regulates the PTEN/PI3K/AKT Signaling Pathway in Breast Cancer Cell Lines
- (2020) Yong-Chul Kim et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Elevated expression of Gab1 promotes breast cancer metastasis by dissociating the PAR complex
- (2019) Xiao Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- CTBP1 depletion on prostate tumors deregulates miRNA/mRNA expression and impairs cancer progression in metabolic syndrome mice
- (2019) Guillermo Nicolás Dalton et al. Cell Death & Disease
- microRNA-21 promotes breast cancer proliferation and metastasis by targeting LZTFL1
- (2019) Hui Wang et al. BMC CANCER
- Incorporating MicroRNA into Molecular Phenotypes of Circulating Tumor Cells Enhances the Prognostic Accuracy for Patients with Metastatic Breast Cancer
- (2019) Weige Tan et al. ONCOLOGIST
- The Regulatory Role of MicroRNAs in Breast Cancer
- (2019) Hui-Yi Loh et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Differential expression of the miR-17-92 cluster and miR-17 family in breast cancer according to tumor type; results from the Norwegian Women and Cancer (NOWAC) study
- (2019) Line Moi et al. Journal of Translational Medicine
- MicroRNAs Contribute to Breast Cancer Invasiveness
- (2019) Ivana Fridrichova et al. Cells
- CLCA2 epigenetic regulation by CTBP1, HDACs, ZEB1, EP300 and miR-196b-5p impacts prostate cancer cell adhesion and EMT in metabolic syndrome disease
- (2018) Juliana Porretti et al. INTERNATIONAL JOURNAL OF CANCER
- microRNA as a systemic intervention in the specific breast cancer subtypes with C-MYC impacts; introducing subtype-based appraisal tool
- (2018) Vida Pourteimoor et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The miR-106b-25 cluster mediates breast tumor initiation through activation of NOTCH1 via direct repression of NEDD4L
- (2018) A. L. Guarnieri et al. ONCOGENE
- CTBP1 and metabolic syndrome induce an mRNA and miRNA expression profile critical for breast cancer progression and metastasis
- (2018) Paula L. Farré et al. Oncotarget
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Clinical Proteomics of Breast Cancer Reveals a Novel Layer of Breast Cancer Classification
- (2018) Gali Yanovich et al. CANCER RESEARCH
- Initiating a National Mammographic Screening Program: The Kuwait Experience Training With a US Cancer Center
- (2018) Victoria L. Mango et al. Journal of the American College of Radiology
- Mutant p53 blocks SESN1/AMPK/PGC-1α/UCP2 axis increasing mitochondrial O2ˉ· production in cancer cells
- (2018) Marco Cordani et al. BRITISH JOURNAL OF CANCER
- Identification of genes associated with survival of breast cancer patients
- (2018) Min Liu et al. Breast Cancer
- DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions
- (2017) Dimitra Karagkouni et al. NUCLEIC ACIDS RESEARCH
- Involvement of miR-106b in tumorigenic actions of both prolactin and estradiol
- (2017) Kuan-Hui Ethan Chen et al. Oncotarget
- miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients
- (2016) András Lánczky et al. BREAST CANCER RESEARCH AND TREATMENT
- Subtype-specific micro-RNA expression signatures in breast cancer progression
- (2016) Vilde D. Haakensen et al. INTERNATIONAL JOURNAL OF CANCER
- Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition
- (2016) Marco Cordani et al. Molecular Oncology
- Unravelling site-specific breast cancer metastasis: a microRNA expression profiling study
- (2016) Willemijne A.M.E. Schrijver et al. Oncotarget
- HER2-encoded mir-4728 forms a receptor-independent circuit with miR-21-5p through the non-canonical poly(A) polymerase PAPD5
- (2016) Inga Newie et al. Scientific Reports
- Identification of MicroRNAs as Breast Cancer Prognosis Markers through the Cancer Genome Atlas
- (2016) Jeremy T-H. Chang et al. PLoS One
- Bone morphogenetic protein 4 regulates microRNA expression in breast cancer cell lines in diverse fashion
- (2015) Emma-Leena Alarmo et al. GENES CHROMOSOMES & CANCER
- Prognostic value of miR-106b expression in breast cancer patients
- (2015) Ruohui Zheng et al. JOURNAL OF SURGICAL RESEARCH
- MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer
- (2015) Gloria Bertoli et al. Theranostics
- Regulation of microRNA biogenesis
- (2014) Minju Ha et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Triple-negative and luminal A breast tumors: differential expression of miR-18a-5p, miR-17-5p, and miR-20a-5p
- (2014) Carlos Marino Cabral Calvano Filho et al. TUMOR BIOLOGY
- Recurrent ESR1–CCDC170 rearrangements in an aggressive subset of oestrogen receptor-positive breast cancers
- (2014) Jamunarani Veeraraghavan et al. Nature Communications
- Integrated genomic analysis of triple-negative breast cancers reveals novel microRNAs associated with clinical and molecular phenotypes and sheds light on the pathways they control
- (2013) Emanuele de Rinaldis et al. BMC GENOMICS
- MiR-106b expression determines the proliferation paradox of TGF-β in breast cancer cells
- (2013) C Gong et al. ONCOGENE
- Key roles for GRB2-associated-binding protein 1, phosphatidylinositol-3-kinase, cyclooxygenase 2, prostaglandin E2 and transforming growth factor alpha in linoleic acid-induced upregulation of lung and breast cancer cell growth
- (2013) M. Mouradian et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Functional characterization of cancer-associated Gab1 mutations
- (2012) C Ortiz-Padilla et al. ONCOGENE
- Sestrin2 Modulates AMPK Subunit Expression and Its Response to Ionizing Radiation in Breast Cancer Cells
- (2012) Toran Sanli et al. PLoS One
- miR-27a is a negative regulator of adipocyte differentiation via suppressing PPARγ expression
- (2010) Sang Yun Kim et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- miR-17-5p promotes human breast cancer cell migration and invasion through suppression of HBP1
- (2010) Hongling Li et al. BREAST CANCER RESEARCH AND TREATMENT
- MicroRNAs: Novel regulators in the hallmarks of human cancer
- (2009) Kai Ruan et al. CANCER LETTERS
- The Tumor Suppressor Protein HBP1 Is a Novel c-Myc-binding Protein That Negatively Regulates c-Myc Transcriptional Activity
- (2009) Julienne R. Escamilla-Powers et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-β1
- (2008) Biyun Qian et al. BREAST CANCER RESEARCH AND TREATMENT
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started